Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and tolerability of Bilastine 20 mg
Q.D., compared to Levocetirizine 5 mg Q.D. and placebo for the treatment of Chronic
Idiopathic Urticaria.